The dimorphic fungus Candida albicans is an interesting microorganism because of the enigmas that surround its relationship with the host, particularly the pathogenicity, dimorphic transition, and mechanisms of host response to colonization and/or invasion (19; for reviews, see references 15 and 37). Although usually harbored as a harmless commensal in the gastrointestinal tract of healthy humans, C. albicans causes morbidity and, in some cases, mortality in immunocompromised hosts (37) . In this respect, candidosis is becoming a life-threatening disease in patients undergoing aggressive chemotherapy and in immunocompromised patients, such as those with human T-cell leukemia virusassociated immunodeficiencies (16, 26, 30, 36) . Morphogenetic studies document the dimorphic properties of C. albicans, which undergoes a transition from the yeast form (Y-Candida) to the hyphal form (H-Candida) (15, 20, 37) . This transition is accompanied by remarkable changes in the expression of surface structures. Antigenic determinants exclusively or predominantly expressed on either Y-Candida or H-Candida have been generally characterized as high-molecular-weight mannoproteins (12, 14, 40, 42) . However, the significance of these antigenic variations in Candida pathogenicity is not clear.
During the early stages of infection, the phagocytic clearance of C. albicans enables the host to remove and destroy most of the Y-Candida. However, the Candida cells that escape the phagocytosis process rapidly convert into H-Candida and invade the organism, where they produce granulomas and cause tissue damage (37) . In this context, any potential ability of the host immunoeffectors to discriminate between the two forms of Candida cells, thus exhibiting different biological responses, is an important issue that remains to be elucidated. The initial information indicated studies of the interaction between Candida cells and phagocytes we showed that murine effector cells of distinct anatomical compartments exhibit different patterns of antiCandida activities (2, 3, 5, 46) , which, in turn, can be modulated by appropriate in vitro and/or in vivo treatments (6, 44, 45, 47) . Furthermore, using cloned macrophage cell lines obtained in vitro by recombinant retroviral infection-of primary bone marrow or microglial cultures (7, 9, 19) , we found that a macrophage accomplishes its anti-Candida activity through a cascade of events that are distinct in biochemical demands and susceptibility to certain cytokines (8, 10) . Since our studies have mainly focused on Y-Candida, it became important to assess the interaction of macrophages with H-Candida.
We show here that ANA-1 macrophages respond to H-Candida but not to the Y-Candida, with increased tumor necrosis factor (TNF) and downregulated lysozyme (LZM) transcription and production. These findings provide the first evidence that macrophages can discriminate between the two forms of C. albicans.
MATERIALS AND METHODS
Cell lines. The ANA-1 murine macrophages, derived by immortalization of bone marrow cells from C57BL/6 mice with a recombinant retrovirus carrying the v-raf and v-myc oncogenes (9, 19) , were cultured in RPMI 1640 medium supplemented with glutamine (4 mM), gentamicin (50 ,ug/ml), and 10% heat-inactivated fetal bovine serum (Hyclone Laboratories, Logan, Utah) (complete medium EcoRI fragment (cloned in from the pUC9 plasmid) was used (13) .
RESULTS
Experiments were performed to assess whether ANA-1 macrophages could differentially modulate TNF or LZM mRNA expression in response to Y-Candida or H-Candida. Cytokine mRNA levels were monitored in cells exposed for 0.5, 1, 2, and 3 h to Y-Candida or H-Candida. ANA-1 cells constitutively expressed detectable levels of both TNF and LZM mRNA (Fig. 1) . Exposure of cells to Y-Candida did not significantly affect the levels of either LZM or TNF mRNA at any of the time points tested. In contrast, ANA-1 cells responded to H-Candida with a marked increase in TNF and downregulation of LZM mRNA levels; the effects were time dependent. No differences in GAPDH mRNA expression were observed when the blots were rehybridized with a GAPDH-specific probe (Fig. 1) . These data indicate that macrophages could differentially modulate gene expression in response to Y-Candida or H-Candida and that only the latter is biologically active.
To determine the dose response of macrophage-gene modulation by H-Candida, ANA-1 cells were exposed to H-Candida for 3 h at E/T ratios of 10:1, 5:1, 1:1, 1:5, and 1:10 and then assessed for TNF and LZM mRNA levels. H-Candida enhanced TNF levels and reduced LZM mRNA levels in a dose-dependent manner (Fig. 2) . Although the E/T ratio of 10:1 was ineffective, the E/T ratio of 5:1 produced partial effects and plateau levels were reached when the effector cell number was equal to or lower than the number of Candida cells. Y-Candida failed to produce any effect at any of the E/T ratios employed (data not shown).
To establish whether the changes in mRNA levels were associated with parallel variations of secreted biological activities, supernatants of ANA-1 cells, incubated for 3 h with H-Candida at various E/T ratios, were tested for TNF or LZM activity. A major increase in TNF levels and a decrease in LZM activities were detected in the supernatants ( demonstrated that the pattern of secreted biological activities paralleled the changes in mRNA levels. To assess whether Y-Candida, which did not affect gene expression, could interact with ANA-1 macrophages, its susceptibility to phagocytosis was measured. ANA-1 cells were incubated with Y-Candida for 1 h (ERT ratio, 1:10), stained with Giemsa, and scored for the presence of phagocytic cells. Y-Candida cells were ingested (Fig. 3A) , whereas H-Candida cells were totally refractory to phagocytosis by ANA-1 macrophages (Fig. 3B) . Similar results were obtained at different E/T ratios and after longer times of coincubation (data not shown). These results demonstrated that the macrophage-activating properties of C. albicans do not correlate with its susceptibility to phagocytosis.
The failure of Y-Candida to modulate gene expression in macrophages could be due to the lack of stimulatory moieties or to a concomitant expression of inhibitory signals. To address this issue, we tested whether ANA-1 macrophages exposed to Y-Candida were still capable of responding to a (Table 2) . Similarly, LPS was active in both cell populations (Table 2) .
Overall, our findings indicate that a macrophage recognizes H-Candida but not Y-Candida as a stimulating signal; however, Y-Candida per se is devoid of inhibitory properties, since it does not prevent the macrophage response to other stimuli. DISCUSSION The main purpose of this study was to investigate whether a macrophage could discriminate between the yeast and hyphal forms of the dimorphic fungus C. albicans. We show that ANA-1 macrophages selectively respond to H-Candida with enhanced TNF levels and downregulated LZM levels, as assessed by evaluation of relative mRNA levels and biological activities.
Firm evidence exists that natural defense mechanisms are crucial in reducing the pathogenic burden of C. albicans in both normal and immunodepressed hosts (15, 37) . Among the cells with potential candidacidal activity, polymorphonuclear leukocytes are undoubtedly the best known and most studied (1, 21, 23, 26, 31) . Macrophages also exert anti-Candida activity; however, their contribution to host defenses is less well defined. Using in vivo models, we previously showed that tissue macrophages may play an important role in protecting the host against C. albicans infections (5, 6, 11, (43) (44) (45) . Furthermore, in vitro data demonstrate that macrophages of different districts constitutively exhibit anti-Candida activity (2, 3, 43, 47) . Such activity can be modulated upon appropriate treatment (8, 10, 47) and is retained after in vivo transfer into syngeneic hosts (11) . Although most of the studies performed have dealt with Y-Candida, initial evidence indicates that macrophages (41) and polymorphonuclear leukocytes and other natural effector cells (4, 22) can affect the hyphal form of the fungus.
In the present report, we demonstrate that the interaction between ANA-1 macrophages and H-Candida results in a consistent augmentation of TNF mRNA levels. The effect is time and dose dependent. Concomitantly, downregulation of LZM mRNA levels occurs. (12, 14, 15, 37) , their immunological or pathogenic role is still a matter of controversy. Evidence indicates that cell wall mannoproteins and cell surface hydrophobicity are involved in the adhesion of the microorganism to host cells (14, 15, 37) . We are currently investigating whether H-Candida-derived cell wall and/or secretory products may be identified as mediators of the phenomenon described in this report.
Other authors have shown that murine splenic macrophages (46) and human peripheral blood monocytes (24) produce TNF upon in vitro exposure to Y-Candida. It is conceivable that in these experimental models there is cooperation among different cell types that is responsible for TNF production and that this cooperation is absent in a single cell population, such as that used in our experimental system. Alternatively, unlike tissue macrophages, ANA-1 macrophages may have additional properties that are responsible for the TNF induction. Extensive studies involving macrophages from different anatomical compartments and/or at different stages of activation will definitively clarify this issue. To date, experiments performed with macrophage cell lines obtained from other anatomical regions by the v-raf and v-myc oncogenes (7, 9) have shown results similar to those described herein for ANA-1 macrophages (data not shown).
Although Y-Candida is unable to modulate TNF and LZM production, it interacts with ANA-1 macrophages to the extent of being ingested. Most of the microorganisms are internalized after 30 min of coculture. On the contrary, H-Candida is not susceptible to phagocytosis; only H-Candida is detectable outside the effector cell, regardless of the length of time in coculture (data not shown). These results indicate that ANA-1 macrophages are comparable to polymorphonuclear leukocytes (22) in their ability to engulf yeast cells but not hyphae. As previously suggested, the most likely explanation is that hyphae are too large to be internalized. Alternatively, structures selectively expressed in H-Candida have phagocytosis-inhibiting properties. In any case, hyphae are processed as extracellular targets. Gene products involved in phagocytosis and/or phagosome-related VOL. 60, 1992 systems, such as LZM, are likely not needed and thus become downregulated in macrophages exposed to H-Candida. Meanwhile, an alternative macrophage strategy occurs, since ANA-1 cells augment TNF mRNA levels in response to H-Candida. This strategy closely resemble that employed against tumor targets. It has been recently shown that monocytes and/or macrophages exhibit enhanced TNF production when exposed to tumor cells (27, 28) .
To our knowledge, there is no evidence for toxic effects of TNF on hyphae, nor have changes been observed in hyphal growth or hyphal susceptibility to macrophage inhibitory effects (data not shown). However, TNF is known to play an important role as an activating factor during infections (29, 44) . Macrophages and other immune system elements respond to TNF with potentiation of a variety of functions, including anti-Candida activity (8, 23, 25) . We have previously shown that, by infecting a mouse with a low-virulence Candida strain, it is possible to establish protection against a subsequent challenge with a lethal variant (44) . This phenomenon is associated with and probably mediated by high levels of cytokines, including TNF, in serum. Our in vitro data demonstrate that ANA-1 macrophages are early TNF producers in response to Candida infection, provided that the fungus has undergone dimorphic transition to the hyphal form. The demonstration that tissue macrophages may share this peculiarity with ANA-1 macrophages will provide straightforward proof that in vivo the encounter of a macrophage with C. albicans triggers an early differential response, depending upon the morphogenetic status of the fungus.
